Argus analyst Marie Ferguson raised the firm’s price target on Equinix (EQIX) to $975 from $900 and keeps a Buy rating on the shares. Equinix has sequentially topped consensus in 2024 and after the ...
We recently compiled a list of the 35 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at where Equinix, Inc. (NASDAQ:EQIX) stands against the other AI stocks that ...
We recently compiled a list of the 15 AI Stocks Trending on Financial Media. In this article, we are going to take a look at ...
Investing.com - Guggenheim raised its price target on Regeneron Pharma (NASDAQ:REGN) to $975.00 from $865.00 on Monday, while maintaining a Buy rating on the stock. The price target increase follows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results